Ligand validation:5LXB

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5LXB designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5LXB_NAG_F_301	16%	14%	0.229	0.806	0.81	3.24	-	8	2	0	93%	0.9333
5LXB_NAG_I_301	14%	38%	0.181	0.741	0.73	1.77	-	4	3	0	93%	0.9333
5LXB_NAG_D_301	4%	26%	0.293	0.67	0.72	2.37	-	6	1	0	93%	0.9333
5LXB_NAG_A_301	1%	39%	0.456	0.688	0.65	1.8	-	2	3	0	93%	0.9333
5LXB_NAG_E_301	1%	37%	0.476	0.617	0.72	1.83	-	4	1	0	93%	0.9333
5LXB_NAG_G_301	0%	61%	0.48	0.488	0.43	1.04	-	1	1	0	93%	0.9333
5LXB_NAG_J_301	0%	58%	0.59	0.6	0.58	1.01	-	1	0	0	93%	0.9333
5LXB_NAG_C_301	0%	49%	0.547	0.425	0.6	1.35	-	3	1	0	93%	0.9333
2WNL_NAG_H_400	64%	61%	0.14	0.938	0.42	1.04	-	-	0	0	100%	0.9333
2YME_NAG_E_1209	32%	19%	0.191	0.864	1.18	2.44	1	6	0	0	100%	0.9333
2XZ5_NAG_D_1216	23%	9%	0.201	0.832	1.97	2.64	5	8	4	0	93%	0.9333
2UZ6_NAG_D_1206	22%	13%	0.167	0.791	1.68	2.43	2	7	0	1	93%	0.9333
5OAJ_NAG_H_301	13%	76%	0.261	0.799	0.3	0.62	-	-	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.